Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;61(2):241-7.
doi: 10.1136/gutjnl-2011-300049. Epub 2011 Jun 5.

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Laurent Peyrin-Biroulet  1 , Alarcos Cieza, William J Sandborn, Michaela Coenen, Yehuda Chowers, Toshifumi Hibi, Nenad Kostanjsek, Gerold Stucki, Jean-Frédéric Colombel; International Programme to Develop New Indexes for Crohn's Disease (IPNIC) group
Collaborators, Affiliations

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

Laurent Peyrin-Biroulet et al. Gut. 2012 Feb.

Abstract

Objective: The impact of inflammatory bowel disease (IBD) on disability remains poorly understood. The World Health Organization's integrative model of human functioning and disability in the International Classification of Functioning, Disability and Health (ICF) makes disability assessment possible. The ICF is a hierarchical coding system with four levels of details that includes over 1400 categories. The aim of this study was to develop the first disability index for IBD by selecting most relevant ICF categories that are affected by IBD.

Methods: Relevant ICF categories were identified through four preparatory studies (systematic literature review, qualitative study, expert survey and cross-sectional study), which were presented at a consensus conference. Based on the identified ICF categories, a questionnaire to be filled in by clinicians, called the 'IBD disability index', was developed.

Results: The four preparatory studies identified 138 second-level categories: 75 for systematic literature review (153 studies), 38 for qualitative studies (six focus groups; 27 patients), 108 for expert survey (125 experts; 37 countries; seven occupations) and 98 for cross-sectional study (192 patients; three centres). The consensus conference (20 experts; 17 countries) led to the selection of 19 ICF core set categories that were used to develop the IBD disability index: seven on body functions, two on body structures, five on activities and participation and five on environmental factors.

Conclusions: The IBD disability index is now available. It will be used in studies to evaluate the long-term effect of IBD on patient functional status and will serve as a new endpoint in disease-modification trials.

PubMed Disclaimer

Conflict of interest statement

Competing interests: J-F Colombel, J Cosnes, T Oresland, L Peryin-Biroulet, W Reinisch, W Sandborn, J Schölmerich, S Travis, G Van Assche, and M Vecchi have received research support from and/or served as consultants for Abbott Laboratories. No potential conflicts (financial, professional, or personal) relevant to the manuscript for the other authors.

Figures

Figure 1
Figure 1
Inflammatory bowel disease disability index.
See this image and copyright information in PMC

References

    1. Loftus EV., Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17 - PubMed
    1. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability and Health. Inflamm Bowel Dis 2010;16:15–22 - PubMed
    1. Casellas F, López-Vivancos J, Vergara M, et al. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis 1999;17:208–18 - PubMed
    1. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992;14:15–19 - PubMed
    1. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804–10 - PubMed

Publication types

MeSH terms